Explore
Validate
Learn
Western blot
ELISA
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1-32133 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- RFX5 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p.
Hou T, Ye L, Wu S
OncoTargets and therapy 2021;14:3991-4003
OncoTargets and therapy 2021;14:3991-4003
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2 The key transcription factor RFX5 critically activated the transcription of LINC00504. ( A ) The expression of RFX5 in breast cancer patients and healthy subjects in The Cancer Genome Atlas (TCGA) database was assessed. ( B and D ) The expression level of RFX5 was detected in MDA-MB-231 and SKBR3 cells after transfection with RFX5 siRNAs or pcDNA-RFX5. ( C and E ) The effect of the altered expression level of RFX5 on the regulation of LINC00504. ( F ) ChIP-qPCR assays showing RFX5 binding to the LINC00504 promoter in BC cells. ( G and H ) ChIP-qPCR assays revealed the enrichment of RFX5 on the LINC00504 promoter in BC cells after transfection with RFX5 siRNA or pcDNA-RFX5. *P
